Clinical Trial Update: STHLM3-MR: Comparing Standard With Targeted Prostate Biopsies [NA]

View source ↗

Summary

The STHLM3-MR trial comparing standard versus targeted prostate biopsies for prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Karolinska Institutet | Conditions: Prostate Cancer | NA | Status: COMPLETED